Atlas Trials

Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis

Clinical trial NCT03828123 · COMPLETED

Trial details

NCT number
NCT03828123
Sponsor
Bioinova, s.r.o.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Start date
2012-01-01
Primary completion
2017-08-18
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.